BACKGROUND: Quality of life (QOL) may be associated with morbidity and survival in end-stage renal disease (ESRD), and is considered to be an important outcome measure for patients with chronic kidney disease (CKD). However, the prognostic role of QOL for survival in CKD remains unclear. We studied the relationship between QOL and risks of ESRD and mortality in CKD patients. METHODS: From 1 January 2007 to 31 December 2007, we prospectively used the Taiwan version of World Health Organization Quality-of-Life Questionnaire (Taiwan version) (WHOQOL-BREF(TW)) with 568 CKD patients at a medical centre in southern Taiwan, and patients were followed up for 1-2 years after enrollment. The primary outcome was the time to dialysis or death. We used Kaplan-Meier curve and Cox proportional hazard model for survival analyses. RESULTS: Of the 568 patients enrolled, 423 were able to complete the questionnaires, and their data were analysed. The median follow-up time was 410 days. Progressive decreases in scores of QOL in all domains were noted with decrease in eGFR. In unadjusted analysis, dialysis and death were associated with lower scores of total and all four domains of WHOQOL-BREF(TW). In adjusted analysis, the total scores and scores of both physical and psychological domains predicted dialysis and mortality (every 1-point decrease hazard ratio (HR): 1.050, 95% CI: 1.008-1.095, P = 0.020; HR: 1.179, CI: 1.033-1.346, P = 0.014; HR: 1.167, CI: 1.016-1.339, P = 0.028, respectively). The adjusted risks of ESRD and mortality also increased in patients in the lowest tertile of psychological domain (P < 0.01), and physical domain and total scores (P < 0.05). CONCLUSIONS: Physical, psychological and total scores of QOL are significantly correlated with increased risks of ESRD and death in CKD patients. QOL should be considered as an independent predictor of risks of ESRD and mortality.
BACKGROUND: Quality of life (QOL) may be associated with morbidity and survival in end-stage renal disease (ESRD), and is considered to be an important outcome measure for patients with chronic kidney disease (CKD). However, the prognostic role of QOL for survival in CKD remains unclear. We studied the relationship between QOL and risks of ESRD and mortality in CKDpatients. METHODS: From 1 January 2007 to 31 December 2007, we prospectively used the Taiwan version of World Health Organization Quality-of-Life Questionnaire (Taiwan version) (WHOQOL-BREF(TW)) with 568 CKDpatients at a medical centre in southern Taiwan, and patients were followed up for 1-2 years after enrollment. The primary outcome was the time to dialysis or death. We used Kaplan-Meier curve and Cox proportional hazard model for survival analyses. RESULTS: Of the 568 patients enrolled, 423 were able to complete the questionnaires, and their data were analysed. The median follow-up time was 410 days. Progressive decreases in scores of QOL in all domains were noted with decrease in eGFR. In unadjusted analysis, dialysis and death were associated with lower scores of total and all four domains of WHOQOL-BREF(TW). In adjusted analysis, the total scores and scores of both physical and psychological domains predicted dialysis and mortality (every 1-point decrease hazard ratio (HR): 1.050, 95% CI: 1.008-1.095, P = 0.020; HR: 1.179, CI: 1.033-1.346, P = 0.014; HR: 1.167, CI: 1.016-1.339, P = 0.028, respectively). The adjusted risks of ESRD and mortality also increased in patients in the lowest tertile of psychological domain (P < 0.01), and physical domain and total scores (P < 0.05). CONCLUSIONS: Physical, psychological and total scores of QOL are significantly correlated with increased risks of ESRD and death in CKDpatients. QOL should be considered as an independent predictor of risks of ESRD and mortality.
Authors: Tanzila Shams; Alexander P Auchus; Suzanne Oparil; Clinton B Wright; Jackson Wright; Anthony J Furlan; Cathy A Sila; Barry R Davis; Sara Pressel; Jose-Miguel Yamal; Paula T Einhorn; Alan J Lerner Journal: Stroke Date: 2017-09-27 Impact factor: 7.914
Authors: Anna C Porter; James P Lash; Dawei Xie; Qiang Pan; Jennifer DeLuca; Radhika Kanthety; John W Kusek; Claudia M Lora; Lisa Nessel; Ana C Ricardo; Julie Wright Nunes; Michael J Fischer Journal: Clin J Am Soc Nephrol Date: 2016-05-31 Impact factor: 8.237
Authors: Usama Feroze; Nazanin Noori; Csaba P Kovesdy; Miklos Z Molnar; David J Martin; Astrid Reina-Patton; Debbie Benner; Rachelle Bross; Keith C Norris; Joel D Kopple; Kamyar Kalantar-Zadeh Journal: Clin J Am Soc Nephrol Date: 2011-04-28 Impact factor: 8.237
Authors: Nasrollah Ghahramani; Vernon M Chinchilli; Jennifer L Kraschnewski; Eugene J Lengerich; Christopher N Sciamanna Journal: Kidney Dis (Basel) Date: 2021-03-31
Authors: Anna Porter; Michael J Fischer; Xuelei Wang; Deborah Brooks; Marino Bruce; Jeanne Charleston; William H Cleveland; Donna Dowie; Marquetta Faulkner; Jennifer Gassman; Leena Hiremath; Cindy Kendrick; John W Kusek; Keith C Norris; Denyse Thornley-Brown; Tom Greene; James P Lash Journal: J Am Soc Nephrol Date: 2014-04-03 Impact factor: 10.121
Authors: Aung Zaw Zaw Phyo; David A Gonzalez-Chica; Nigel P Stocks; Elsdon Storey; Robyn L Woods; Anne M Murray; Suzanne G Orchard; Raj C Shah; Danijela Gasevic; Rosanne Freak-Poli; Joanne Ryan Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.472
Authors: Jennifer C Davis; Stirling Bryan; John R Best; Linda C Li; Chun Liang Hsu; Caitlin Gomez; Kelly A Vertes; Teresa Liu-Ambrose Journal: Health Qual Life Outcomes Date: 2015-07-15 Impact factor: 3.186
Authors: Norhayati Ibrahim; Sharlene S L Teo; Normah Che Din; Abdul Halim Abdul Gafor; Rozmi Ismail Journal: PLoS One Date: 2015-07-01 Impact factor: 3.240
Authors: Moniek C M de Goeij; Gurbey Ocak; Joris I Rotmans; Jan-Willem Eijgenraam; Friedo W Dekker; Nynke Halbesma Journal: PLoS One Date: 2014-04-03 Impact factor: 3.240